About 70 Mg Dasatinib Tablets
70 Mg Dasanic (Dasatinib) Tablets stand as a must-have in elite oncology care, engineered for formidable efficacy against chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Celebrated for their targeted therapy, these heroic tablets belong to the top class of tyrosine kinase inhibitors, offering advanced oral administration for patient comfort. Each round, film-coated tablet contains 70 mg of Dasatinib, presenting a reliable solution for oncologists requiring prescription-only cancer treatments. Secured in moisture-resistant blister packs or bottles, Dasanic tablets by reputed manufacturers set the standard for leading cancer therapy.
Competitive Advantages and Key Features
Dasanic 70 mg tablets exemplify a top-tier choice for cancer treatment, offering high efficacy through targeted therapy. Designed for oral intake, the administration method ensures both convenience and compliance in clinical settings. With their formidable action against leukemia and their celebrated quick onset, these tablets deliver reliable results for oncologists. The heroically precise formulation minimizes off-target effects, while their robust shelf life of 24 months ensures lasting potency for ongoing patient care.
Packaging, Certifications, and Supply Logistics
Dasanic tablets are securely packed in moisture-protected blister packs or bottles, with a standard pack size of 30 tablets per box, though options may vary. Each batch's certifications are clearly stated on the packaging, reflecting stringent quality control. Competitive rates are provided for suppliers, traders, and exporters in India, supporting efficient exchange and logistics solutions. Sample availability upon request ensures confidence before finalizing large orders, enhancing trust and supply chain reliability.
FAQ's of 70 Mg Dasatinib Tablets:
Q: How should 70 mg Dasanic (Dasatinib) tablets be administered?
A: The tablets are designed for oral administration and should be taken as directed by an oncologist, ideally at the same time each day for consistent blood levels.
Q: What are the key clinical uses of Dasanic 70 mg tablets?
A: Dasanic 70 mg is primarily used in the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) as a targeted tyrosine kinase inhibitor.
Q: When should a patient avoid taking Dasanic tablets?
A: Patients with known hypersensitivity to Dasatinib or any tablet excipients should not use this medication. Consultation with an oncologist is essential before starting therapy.
Q: Where can healthcare providers source Dasanic 70 mg tablets?
A: Dasanic tablets are distributed, exported, and supplied in India through authorized distributors or traders, and are available via prescription after verification.
Q: What process is followed for storing Dasanic 70 mg tablets?
A: Store the tablets below 30C in a tightly closed container, in a dry place, protected from light and moisture to preserve their efficacy and shelf life.
Q: What are the major benefits of using Dasanic for leukemia therapy?
A: Dasanic offers elite, targeted therapy that effectively manages leukemia with oral dosing and demonstrates high efficacy, aiding in improved patient outcomes.